WYE WILLOWS LTD
Company number 13112895 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
WYE WILLOWS LTD - Analysis Report
Company Number: 13112895
Analysis Date: 2025-07-19 12:56 UTC
Financial Health Assessment of WYE WILLOWS LTD
1. Financial Health Score: B
WYE WILLOWS LTD demonstrates solid financial health for a young micro-entity with continuous growth in turnover, net assets, and profitability. The company is maintaining a healthy cash position and shows no signs of distress or liquidity issues. However, modest scale and limited fixed assets suggest the company is still in an early growth phase, hence a "B" rating reflects good current health with room for strengthening operational scale and asset base.
2. Key Vital Signs
| Metric | Latest Values (2024) | Interpretation |
|---|---|---|
| Turnover | £13,170 | Increasing revenue indicates growing sales activity and market acceptance, positive symptom of business vitality. |
| Profit for the Period | £8,390 | Healthy profit margin (~64%), showing efficient cost management and profitability. |
| Fixed Assets | £1 | Minimal long-term asset investment, typical for startup or service-based micro business. |
| Current Assets | £10,833 | Strong liquidity, cash or receivables available to cover short-term obligations. |
| Net Current Assets | £10,833 | Positive working capital, indicating the company can comfortably meet immediate liabilities. |
| Total Net Assets | £10,834 | Increasing equity base, reflecting retained earnings growth and financial stability. |
| Employees | 0 | No staff employed, which may limit operational capacity but also keeps overheads low. |
3. Diagnosis: Financial Symptom Analysis
- Healthy Cash Flow & Liquidity: The company shows a robust net current asset position, signaling a healthy cash flow situation. This is like a patient with strong pulse and normal blood pressure, indicating no immediate liquidity crisis.
- Growth in Revenue & Profit: The turnover more than doubled from £9,293 in 2023 to £13,170 in 2024, with profit increasing significantly to £8,390. This suggests the business model is gaining traction and costs are well controlled.
- Minimal Fixed Assets: With only £1 in fixed assets, the company is likely asset-light, relying on operational or service activities rather than heavy capital investment. This is typical for micro companies but may limit scalability or collateral for finance.
- No Employees: The absence of employees may signal a sole trader or director-operated business. While it reduces overhead, it might constrain growth or operational bandwidth.
- No Liabilities Reported: No current liabilities were reported, which is a positive sign showing no short-term debts or payables—similar to a patient free of infections or inflammations causing distress.
Overall, the financial data reveals a young, lean company with positive growth signs, strong liquidity, and profitability, but still modest in scale and asset investment.
4. Recommendations for Financial Wellness Improvement
- Consider Scaling Operations: Hiring key personnel or contractors could increase operational capacity and allow the business to capitalize on growing demand.
- Invest in Fixed Assets or Technology: Strategic investment in equipment, technology, or systems may improve efficiency and support growth, akin to strengthening a patient’s immune system.
- Build Reserves for Contingencies: While current liquidity is healthy, setting aside reserves or establishing a credit line would prepare the company for unexpected downturns or investment opportunities.
- Monitor Cost of Materials: Although cost control is good, the company should continue monitoring materials costs to maintain profit margins as turnover grows.
- Plan for Tax and Compliance: Ensure timely filing and compliance to avoid penalties and maintain good standing with Companies House.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.